Literature DB >> 3394588

Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients.

M Garcia-Caballero1, E Neugebauer, R Campos, I Nunez de Castro, C Vara-Thorbeck.   

Abstract

Following numerous reports of high histidine decarboxylase (HDC) activity in tumour-bearing animals, the present work was designed to determine the activity of this enzyme in normal and tumour tissues in a series of ten surgical patients with colorectal carcinoma. Significantly increased HDC activity, almost double that of normal tissues, was found in specimens from extirpated human tumours. These results, obtained under reliable sampling and measurement conditions indicated that changes in the enzymic activity of HDC may have a significant role in the development of colorectal tumour cells. Inhibition of the enzyme activity in human cancer subjects may retard or impede tumour growth and perhaps limit the spread of metastases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394588     DOI: 10.1007/bf02142587

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

1.  Further studies on the histamine metabolism in the M-2 adenocarcinoma.

Authors:  A J Scolnick; M C Rubio; L L Colombo; R R Comolli; R A Caro
Journal:  Biomed Pharmacother       Date:  1984       Impact factor: 6.529

2.  Causal relationship between a tumour growth and the changes in histamine metabolism in tissues of sarcoma-bearing rat.

Authors:  D Kierska; K Sasiak; T Biegański; C Maśliński
Journal:  Agents Actions       Date:  1987-04

3.  Stimulation of histamine synthesis from tumour cells by concanavalin A and A23187.

Authors:  H Nolte; P Stahl Skov; H Loft
Journal:  Agents Actions       Date:  1987-04

4.  A modified Schayer procedure for the estimation of histidine decarboxylase activity: its application on tissue extracts from gastric mucosa of various mammals.

Authors:  E Neugebauer; W Lorenz
Journal:  Agents Actions       Date:  1982-04

5.  Successful tumour immunotherapy with cimetidine in mice.

Authors:  M E Osband; D Hamilton; Y J Shen; E Cohen; M Shlesinger; P Lavin; A Brown; R McCaffrey
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

6.  Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.

Authors:  J Bartholeyns; M Bouclier
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Histamine levels in blood and other tissues of male and female C3H mice. II. Mice carrying a 3-methyl-cholanthrene-induced tumor [proceedings].

Authors:  P Scheinmann; B Lebel; N R Lynch; J C Salomon; J R Paupe; C Burtin
Journal:  Agents Actions       Date:  1979-04

8.  The influence of carcinoma growth on diamine oxidase activity in human gastrointestinal tract.

Authors:  J Kusche; T Biegański; R Hesterberg; C D Stahlknecht; K D Feussner; I Stahlenberg; W Lorenz
Journal:  Agents Actions       Date:  1980-04

9.  Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H1 and H2 histamine receptors.

Authors:  C Burtin; P Scheinmann; J C Salomon; G Lespinats; P Canu
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  9 in total
  11 in total

1.  Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.

Authors:  Woo Hyun Paik; Ji Kon Ryu; Kyoung-Sin Jeong; Jin Myung Park; Byeong Jun Song; Sang Hyub Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Gut Microbe-Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production.

Authors:  Chunxu Gao; Bhanu Priya Ganesh; Zhongcheng Shi; Rajesh Rasik Shah; Robert Fultz; Angela Major; Susan Venable; Monica Lugo; Kathleen Hoch; Xiaowei Chen; Anthony Haag; Timothy C Wang; James Versalovic
Journal:  Am J Pathol       Date:  2017-09-13       Impact factor: 4.307

Review 3.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

4.  Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma.

Authors:  Nabil M Abdel-Hamid; Amer Hasan Abdullah
Journal:  Clin Exp Med       Date:  2018-11-20       Impact factor: 3.984

5.  Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma.

Authors:  Martin Grimm; Michael Krimmel; Dorothea Alexander; Adelheid Munz; Susanne Kluba; Constanze Keutel; Juergen Hoffmann; Joachim Polligkeit; Siegmar Reinert; Sebastian Hoefert
Journal:  Clin Oral Investig       Date:  2012-07-11       Impact factor: 3.573

Review 6.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

7.  Changes in histamine synthesis, tissue content and catabolism in human breast cancer.

Authors:  M Garcia-Caballero; E Neugebauer; F Rodriguez; I Nuñez de Castro; A Heredia; E Oosting; C Vara Thorbeck
Journal:  Agents Actions       Date:  1989-04

8.  Effects of histamine, H1, H2 and Hic receptor antagonists and alpha-fluoromethylhistidine on the growth of human colorectal cancer in the subrenal capsule assay.

Authors:  E Suonio; L Tuomisto; E Alhava
Journal:  Agents Actions       Date:  1994-06

9.  Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.

Authors:  Zhengyu Fang; Wantong Yao; Yi Xiong; Jiana Li; Li Liu; Lei Shi; Wei Zhang; Chao Zhang; Liping Nie; Jun Wan
Journal:  BMC Cancer       Date:  2011-05-24       Impact factor: 4.430

10.  Proliferative Effects of Histamine on Primary Human Pterygium Fibroblasts.

Authors:  Zhenwei Qin; Qiuli Fu; Lifang Zhang; Houfa Yin; Xiuming Jin; Qiaomei Tang; Danni Lyu; Ke Yao
Journal:  Mediators Inflamm       Date:  2016-10-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.